Status:
COMPLETED
Diarrhea Predominant Irritable Bowel Syndrome in Females
Lead Sponsor:
Bausch Health Americas, Inc.
Conditions:
Irritable Bowel Syndrome
Eligibility:
FEMALE
18+ years
Phase:
PHASE2
Brief Summary
Clinical Trial with TRN-002 in Women with Irritable Bowel Syndrome (IBS) The purpose of this study is to investigate the safety and effectiveness of a new investigational drug in women for the treatm...
Detailed Description
Clinical Trial with TRN-002 in Women with Irritable Bowel Syndrome (IBS) The purpose of this study is to investigate the safety and effectiveness of a new investigational drug in women for the treatm...
Eligibility Criteria
Inclusion
- Females at least 18 years of age
- Diagnosis of diarrhea predominant Irritable Bowel Syndrome
- Willingness to make daily calls on a touch-tone telephone
- Willingness to have an endoscopic and/or radiologic bowel evaluation, if you have not received one in the past 5 years.
- Willingness to take an approved method of birth control (if required)
Exclusion
- Serious medical or surgical conditions
- Colon Cancer, Crohns Disease or Ulcerative Colitis
- Pregnant or breast feeding
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT00461526
Start Date
October 1 2006
End Date
December 1 2007
Last Update
November 25 2019
Active Locations (43)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Research Associates, LLC
Huntsville, Alabama, United States, 35801
2
Radiant Research
Chandler, Arizona, United States, 85225
3
Genova Clinical Research
Tucson, Arizona, United States, 85741
4
Advanced Clinical Research Institute
Anaheim, California, United States, 92801